Without Graphite, There Would Be ZERO EV Batteries!
Investors constantly hear that lithium is the key to powering the transition to green energy. Truth is, today's EV batteries contain more graphite in volume than any other essential ingredients.
See This Special Report to Get the Full Story
Eric F. Y. Thepaut net worth and biography

Eric Thepaut Biography and Net Worth

Eric Thépaut is our executive vice president and president, Europe, Middle East and Africa, a position he has held since February 2020. Prior to his current role, he was senior vice president and president, Europe, Middle East and Africa from December 2017 to January 2020, and senior vice president and president, Europe from January 2015 to December 2017. He also served as vice president Interventional Cardiology & Structural Heart, Europe, from December 2012 to December 2015. He joined Boston Scientific Europe, in 1996, as a business finance manager and earned roles of increasing responsibility in marketing and finance including vice president, Finance, Europe, general manager and vice president, France, and general manager and vice president of the France Group, comprised of France, Benelux and Middle East North Africa. Mr. Thépaut is a member of our Global Council for Inclusion. Before joining Boston Scientific, Mr. Thépaut held management positions in treasury operations and auditing at Nestlé and financial planning and analysis at Apple, Inc. (then Apple Computer, Inc.). Mr. Thépaut earned his M.B.A. at Paris Dauphine University.

What is Eric F. Y. Thepaut's net worth?

The estimated net worth of Eric F. Y. Thepaut is at least $2.64 million as of November 18th, 2022. Mr. Thepaut owns 57,534 shares of Boston Scientific stock worth more than $2,637,934 as of December 1st. This net worth approximation does not reflect any other investments that Mr. Thepaut may own. Learn More about Eric F. Y. Thepaut's net worth.

How do I contact Eric F. Y. Thepaut?

The corporate mailing address for Mr. Thepaut and other Boston Scientific executives is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. Boston Scientific can also be reached via phone at (508) 683-4000 and via email at [email protected] Learn More on Eric F. Y. Thepaut's contact information.

Has Eric F. Y. Thepaut been buying or selling shares of Boston Scientific?

During the past quarter, Eric F. Y. Thepaut has sold $638,749.44 of Boston Scientific stock. Most recently, Eric Francis Yves Thepaut sold 14,952 shares of the business's stock in a transaction on Friday, November 18th. The shares were sold at an average price of $42.72, for a transaction totalling $638,749.44. Following the completion of the sale, the executive vice president now directly owns 57,534 shares of the company's stock, valued at $2,457,852.48. Learn More on Eric F. Y. Thepaut's trading history.

Who are Boston Scientific's active insiders?

Are insiders buying or selling shares of Boston Scientific?

During the last twelve months, insiders at the medical equipment provider sold shares 28 times. They sold a total of 556,836 shares worth more than $23,061,549.08. The most recent insider tranaction occured on November, 29th when Director Nelda J Connors sold 18,196 shares worth more than $809,176.12. Insiders at Boston Scientific own 0.7 % of the company. Learn More about insider trades at Boston Scientific.

Information on this page was last updated on 11/29/2022.

Eric F. Y. Thepaut Insider Trading History at Boston Scientific

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2022Sell14,952$42.72$638,749.4457,534View SEC Filing Icon  
8/1/2022Sell20,676$40.99$847,509.2472,486View SEC Filing Icon  
8/5/2021Sell41,741$44.14$1,842,447.74View SEC Filing Icon  
11/26/2019Sell22,487$42.70$960,194.9098,844View SEC Filing Icon  
2/27/2019Sell11,980$39.94$478,481.20110,169View SEC Filing Icon  
11/29/2018Sell15,298$36.74$562,048.5298,884View SEC Filing Icon  
5/17/2018Sell20,015$30.15$603,452.25View SEC Filing Icon  
See Full Table

Eric F. Y. Thepaut Buying and Selling Activity at Boston Scientific

This chart shows Eric Francis Yves Thepaut's buying and selling at Boston Scientific by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Boston Scientific Company Overview

Boston Scientific logo
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Read More

Today's Range

Now: $45.91
Low: $45.45
High: $46.15

50 Day Range

MA: $41.37
Low: $38.14
High: $44.50

2 Week Range

Now: $45.91
Low: $34.98
High: $47.49

Volume

129,793 shs

Average Volume

5,456,538 shs

Market Capitalization

$65.76 billion

P/E Ratio

109.31

Dividend Yield

N/A

Beta

0.84
Without Graphite, There Would Be ZERO EV Batteries!
Investors constantly hear that lithium is the key to powering the transition to green energy. Truth is, today's EV batteries contain more graphite in volume than any other essential ingredients.
See This Special Report to Get the Full Story